As approximately half of the causative genes for hereditary breast cancer are genes other than BRCA1/2, multigene panel testing may be beneficial, especially when there is a strong family history of the disease or when the disease occurs at a young age and a BRCA1/2 gene variant is absent [19, 20]. The gene discussed is BRCA1; the disease is breast carcinoma.